Mark McDade, Director: Tourmaline Bio TRML Buy · Filed 24/01/31

Trade details

Type: Insider buy
Amount: $3,250,000
Shares · price: 100,000 sh · $32.50 a share
Held after: 448,431 sh
Stock: Tourmaline Bio TRML
Person: Mark McDadeDirector
Trade date: 24/01/29
Filed: 24/01/31
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +28.7%

Tourmaline Bio trades, last 26 weeks

What else happened in Tourmaline Bio around then

Filed or reported within 30 days of the trade day · 23/12/30~24/02/28

Mark McDade's recent trades

Mark McDade10% Owner
BuyJasper Therapeutics
Buy
Jasper Therapeutics
JSPR
$4M
2,666,666 sh
$4M
Filed 23/04/11
Traded 23/01/27